These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1836234)

  • 1. Evaluation of the calcium channel-blocking agents diltiazem and verapamil for treatment of feline hypertrophic cardiomyopathy.
    Bright JM; Golden AL; Gompf RE; Walker MA; Toal RL
    J Vet Intern Med; 1991; 5(5):272-82. PubMed ID: 1836234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for or against the efficacy of calcium channel blockers for management of hypertrophic cardiomyopathy in cats.
    Bright JM; Golden AL
    Vet Clin North Am Small Anim Pract; 1991 Sep; 21(5):1023-34. PubMed ID: 1683045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparable effects of oral diltiazem and verapamil in the treatment of hypertrophic cardiomyopathy. Double-blind crossover study.
    Toshima H; Koga Y; Nagata H; Toyomasu K; Itaya K; Matoba T
    Jpn Heart J; 1986 Sep; 27(5):701-15. PubMed ID: 3546779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in left ventricular diastolic function during intravenous and oral diltiazem therapy in patients with hypertrophic cardiomyopathy: an echocardiographic study.
    Suwa M; Hirota Y; Kawamura K
    Am J Cardiol; 1984 Nov; 54(8):1047-53. PubMed ID: 6541866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effects of atrial fibrillation and syncope induced by calcium-channel blockers in hypertrophic cardiomyopathy.
    Doiuchi J; Hamada M; Ochi T; Ito T; Kokubu T
    Clin Cardiol; 1985 Mar; 8(3):176-9. PubMed ID: 4038927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benazepril and subclinical feline hypertrophic cardiomyopathy: a prospective, blinded, controlled study.
    Taillefer M; Di Fruscia R
    Can Vet J; 2006 May; 47(5):437-45. PubMed ID: 16734369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.
    Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL
    Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diltiazem-induced left ventricular mass regression in hypertensive patients.
    Weiss RJ; Bent B
    J Clin Hypertens; 1987 Jun; 3(2):135-43. PubMed ID: 2956372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echocardiography, electrocardiography, and radiography of cats with dilatation cardiomyopathy, hypertrophic cardiomyopathy, and hyperthyroidism.
    Moise NS; Dietze AE; Mezza LE; Strickland D; Erb HN; Edwards NJ
    Am J Vet Res; 1986 Jul; 47(7):1476-86. PubMed ID: 2943198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical signs associated with severe ST segment elevation in three cats with a hypertrophic cardiomyopathy phenotype.
    Seo J; Kurosawa TA; Borgeat K; Novo Matos J; Hutchinson JC; Arthurs OJ; Luis Fuentes V
    J Vet Cardiol; 2024 Aug; 54():30-37. PubMed ID: 39004067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic, electrocardiographic, and radiographic detection of cardiomegaly in hyperthyroid cats.
    Moise NS; Dietze AE
    Am J Vet Res; 1986 Jul; 47(7):1487-94. PubMed ID: 2943199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of nifedipine, verapamil and diltiazem on pulmonary vascular resistance and vasoconstrictors in cats.
    Erdemli O; Hao Q; Cai B; Lippton HL; Hyman A
    Arch Int Pharmacodyn Ther; 1994; 328(2):165-79. PubMed ID: 7535994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy].
    Cosnay P; Fauchier JP; Lang M; Casset D; Raynaud P; Lavigne G; Itti R
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):346-55. PubMed ID: 3113357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy].
    Crittin J; Mayor C; Bloch A
    Ann Cardiol Angeiol (Paris); 1984 Apr; 33(3):185-9. PubMed ID: 6375537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil.
    Lundström T; Rydén L
    J Am Coll Cardiol; 1990 Jul; 16(1):86-90. PubMed ID: 2358610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of extended-release diltiazem once daily for cats with hypertrophic cardiomyopathy.
    Wall M; Calvert CA; Sanderson SL; Leonhardt A; Barker C; Fallaw TK
    J Am Anim Hosp Assoc; 2005; 41(2):98-103. PubMed ID: 15767652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of diltiazem on diastolic performance of the hypertrophied left ventricle in patients with systemic hypertension and hypertrophic cardiomyopathy].
    Matsumoto M; Nakajima S; Fukushima M; Maeda T; Yasui K; Matsuyama T; Shimazu T; Hamanaka Y; Inoue M; Abe H
    J Cardiogr; 1983 Dec; 13(4):905-11. PubMed ID: 6236268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical response and effects on left ventricular function of isosorbide dinitrate added to propranolol or diltiazem monotherapy in patients with chronic stable angina.
    Humen DP; Kostuk WJ
    Can J Cardiol; 1991 Mar; 7(2):74-80. PubMed ID: 2049686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.